Jump to Main Content
Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012–2016
- Pike, Jamison, Leidner, Andrew J., MacNeil, Jessica R., Cohn, Amanda C.
- Vaccine 2019 v.37 no.1 pp. 7-10
- discount rate, immunization, models, public health, vaccines, United States
- We identified 16 Advisory Committee on Immunization Practices (ACIP) presentations from 2012 to 2016 that indicated 'cost' or 'economic' content. Characteristics were reviewed, abstracted, and tabulated to quantify and assess the transparency and consistency of economic evidence presented to ACIP. To assess transparency, we documented if each study identified author affiliation, conflicts of interest, study limitations, a clearly described model structure and other model attributes. To assess consistency, we identified the frequency of specific modeling choices, including the perspective, types of health outcomes considered, inclusion of specific types of costs, discount rate, and use of sensitivity analyses. Our results indicate that the content in these presentations appear to be transparent overall and consistent in several important areas, such as study perspective and health outcomes. However, we find the inclusion of particular types of direct costs, indirect costs, program costs, and sensitivity analyses are areas that could improve consistency.